Quanterix Corporation Payments to Acquire Other Property, Plant, and Equipment
Quanterix Corporation (QTRX) reported Payments to Acquire Other Property, Plant, and Equipment of $121.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment · last filed 2026-03-02
- Quanterix Corporation payments to acquire other property, plant, and equipment for the quarter ending 2025-12-31 was -$108.00K, a 124.11% decline year-over-year.
- Quanterix Corporation payments to acquire other property, plant, and equipment for the quarter ending 2025-09-30 was -$276.00K.
- Quanterix Corporation payments to acquire other property, plant, and equipment for the quarter ending 2025-06-30 was -$17.00K, a 102.30% decline year-over-year.
- Quanterix Corporation payments to acquire other property, plant, and equipment for the quarter ending 2025-03-31 was $522.00K, a 135.14% increase year-over-year.
- Quanterix Corporation payments to acquire other property, plant, and equipment for fiscal 2025 was $121.00K, a 90.16% decline from fiscal 2024.
- Quanterix Corporation payments to acquire other property, plant, and equipment for fiscal 2024 was $1.23M, a 193.56% increase from fiscal 2023.
- Quanterix Corporation payments to acquire other property, plant, and equipment for fiscal 2023 was $419.00K, a 175.66% increase from fiscal 2022.
- Quanterix Corporation payments to acquire other property, plant, and equipment for fiscal 2022 was $152.00K, a 33.62% decline from fiscal 2021.
| Period end | Payments to Acquire Other Property, Plant, and Equipment 3 month | Payments to Acquire Other Property, Plant, and Equipment 6 month | Payments to Acquire Other Property, Plant, and Equipment 9 month | Payments to Acquire Other Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$384.00K derived: sum of 2 quarters · filed 2026-03-02 | -$401.00K derived: sum of 3 quarters · filed 2026-03-02 | $121.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | -$276.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$293.00K derived: sum of 2 quarters · filed 2025-11-10 | $229.00K 10-Q · filed 2025-11-10 | $677.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2025-06-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $505.00K 10-Q · filed 2025-08-07 | $953.00K derived: sum of 3 quarters · filed 2026-03-02 | $773.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2025-03-31 | $522.00K 10-Q · filed 2025-05-12 | $970.00K derived: sum of 2 quarters · filed 2026-03-02 | $790.00K derived: sum of 3 quarters · filed 2026-03-02 | $1.53M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-12-31 | $448.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $268.00K derived: sum of 2 quarters · filed 2026-03-02 | $1.01M derived: sum of 3 quarters · filed 2026-03-02 | $1.23M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $560.00K derived: sum of 2 quarters · filed 2025-11-10 | $782.00K 10-Q · filed 2025-11-10 | $1.20M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $740.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $962.00K 10-Q · filed 2025-08-07 | $1.38M derived: sum of 3 quarters · filed 2026-03-02 | $1.38M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $222.00K 10-Q · filed 2025-05-12 | $641.00K derived: sum of 2 quarters · filed 2026-03-02 | $641.00K derived: sum of 3 quarters · filed 2026-03-02 | $494.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $419.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $419.00K derived: sum of 2 quarters · filed 2026-03-02 | $272.00K derived: sum of 3 quarters · filed 2026-03-02 | $419.00K 10-K · filed 2026-03-02 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-12-26 | -$147.00K derived: sum of 2 quarters · filed 2024-12-26 | $0.00 10-Q · filed 2024-12-26 | |
| 2023-06-30 | -$147.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-12-26 | $0.00 10-Q/A · filed 2024-12-26 | ||
| 2023-03-31 | $147.00K 10-Q/A · filed 2024-12-26 | |||
| 2022-12-31 | $152.00K 10-K · filed 2025-03-17 | |||
| 2021-12-31 | $229.00K 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |